Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
KMT2A mutation
i
Other names:
KMT2A, Lysine Methyltransferase 2A, Histone-Lysine N-Methyltransferase 2A, CXXC7, TRX1, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila), Lysine (K)-Specific Methyltransferase 2A, CXXC-Type Zinc Finger Protein 7, Lysine N-Methyltransferase 2A, Zinc Finger Protein HRX, Trithorax-Like Protein, HTRX1, MLL1A, MLL1, MLL, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax (Drosophila) Homolog), Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 1, Myeloid/Lymphoid Or Mixed
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4297
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
KMT2A mutation
Solid Tumor
KMT2A mutation
Solid Tumor
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
KMT2A mutation
Leukemia
KMT2A mutation
Leukemia
JNJ-6617
Sensitive: C3 – Early Trials
JNJ-6617
Sensitive
:
C3
JNJ-6617
Sensitive: C3 – Early Trials
JNJ-6617
Sensitive
:
C3
KMT2A mutation
Acute Myelogenous Leukemia
KMT2A mutation
Acute Myelogenous Leukemia
venetoclax + JNJ-6617
Sensitive: D – Preclinical
venetoclax + JNJ-6617
Sensitive
:
D
venetoclax + JNJ-6617
Sensitive: D – Preclinical
venetoclax + JNJ-6617
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.